TIM
PTLA

Tortoise Investment Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Tortoise Investment Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-164
Closed -$6K – 582
2018
Q2 		$6K Hold
164
– – ﹤0.01% 465
2018
Q1 		$5K Hold
164
– – ﹤0.01% 455
2017
Q4 		$8K Hold
164
– – ﹤0.01% 419
2017
Q3 		$9K Hold
164
– – ﹤0.01% 381
2017
Q2 		$9K Buy
+164
New +$6.57K ﹤0.01% 376

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tortoise Investment Management's PTLA Position: Q3 2018 in Review

Tortoise Investment Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2018, closing a stake of 164 shares — an estimated $6K sold.

Tortoise Investment Management first reported a position in PTLA in Q2 2017 and held it in 5 quarters. The position peaked at $9K in Q3 2017. 197 funds tracked by Wall St. Rank hold PTLA as of Q3 2018.

  • Tortoise Investment Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
  • Tortoise Investment Management sold 164 Portola Pharmaceuticals, Inc. shares in Q3 2018, an estimated $6K.
  • Tortoise Investment Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2017 and held it in 5 quarters.
  • Tortoise Investment Management's Portola Pharmaceuticals, Inc. position peaked at $9K in Q3 2017.
  • 197 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2018.

Based on Tortoise Investment Management's 13F filing for Q3 2018, filed 20 Nov 2018.